Cargando…

Value of Hcy combined with Framingham score for predicting macrovascular disease in elderly patients with type 2 diabetes

To analyze the predictive value of homocysteine (Hcy) combined with the Framingham risk score for cardio- and cerebrovascular disease in elderly patients with type 2 diabetes mellitus (T2DM) to provide a reference for clinical treatment. We retrospectively reviewed the clinical data of 1036 elderly...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lei, Wang, Zhao Hui, Liu, Ling Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553110/
https://www.ncbi.nlm.nih.gov/pubmed/37800767
http://dx.doi.org/10.1097/MD.0000000000035401
_version_ 1785116096075923456
author Wang, Lei
Wang, Zhao Hui
Liu, Ling Peng
author_facet Wang, Lei
Wang, Zhao Hui
Liu, Ling Peng
author_sort Wang, Lei
collection PubMed
description To analyze the predictive value of homocysteine (Hcy) combined with the Framingham risk score for cardio- and cerebrovascular disease in elderly patients with type 2 diabetes mellitus (T2DM) to provide a reference for clinical treatment. We retrospectively reviewed the clinical data of 1036 elderly patients with T2DM admitted to our hospital between July 2017 and July 2022. The patients were divided into occurrence (n = 438) and control (n = 598) groups based on the incidence of cardio- or cerebrovascular disease. Univariate and multivariate logistic analyses were used to analyze the factors associated with cardio-cerebral small-vessel disease in the elderly patients with T2DM. The predictive value of Hcy combined with the Framingham score for cardio- and cerebrovascular diseases in elderly patients with T2DM was determined using receiver operating characteristic curves. Univariate analysis showed that the occurrence group had significantly higher Framingham score, systolic blood pressure (SBP), total cholesterol (TC), fasting blood glucose (FBG), 2-hour postprandial plasma glucose, Hcy, glycated hemoglobin, smoking history, and disease duration than the control group (all P < .05). Food preferences, sleep duration, physical exercise, high density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol levels were significantly lower in the occurrence group than in the control group (all P < .05). Multivariate logistic analysis showed that smoking history, duration of diabetes, Framingham score, SBP, TC, FBG, HDL-C, 2h postprandial plasma glucose, and Hcy levels were risk factors for cardio- and cerebrovascular disease in elderly patients with T2DM. The area under the curve for Hcy and Framingham scores was 0.741 (95% confidence interval [CI]: 0.635–1.871) and 0.717 (95% CI: 0.601–0.856), respectively. Hcy combined with the Framingham score demonstrated a significantly higher predictive value (0.852, 95% CI: 0.741–0.979). Long smoking history, long diabetes duration, high Framingham score, high SBP, high TC, high FBG, low HDL-C, and high Hcy levels are risk factors for cardio-cerebrovascular disease in elderly patients with T2DM. In addition, Hcy level combined with the Framingham score demonstrated superior predictive power for cardio- and cerebrovascular disease in elderly patients with T2DM.
format Online
Article
Text
id pubmed-10553110
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-105531102023-10-06 Value of Hcy combined with Framingham score for predicting macrovascular disease in elderly patients with type 2 diabetes Wang, Lei Wang, Zhao Hui Liu, Ling Peng Medicine (Baltimore) Observational Study To analyze the predictive value of homocysteine (Hcy) combined with the Framingham risk score for cardio- and cerebrovascular disease in elderly patients with type 2 diabetes mellitus (T2DM) to provide a reference for clinical treatment. We retrospectively reviewed the clinical data of 1036 elderly patients with T2DM admitted to our hospital between July 2017 and July 2022. The patients were divided into occurrence (n = 438) and control (n = 598) groups based on the incidence of cardio- or cerebrovascular disease. Univariate and multivariate logistic analyses were used to analyze the factors associated with cardio-cerebral small-vessel disease in the elderly patients with T2DM. The predictive value of Hcy combined with the Framingham score for cardio- and cerebrovascular diseases in elderly patients with T2DM was determined using receiver operating characteristic curves. Univariate analysis showed that the occurrence group had significantly higher Framingham score, systolic blood pressure (SBP), total cholesterol (TC), fasting blood glucose (FBG), 2-hour postprandial plasma glucose, Hcy, glycated hemoglobin, smoking history, and disease duration than the control group (all P < .05). Food preferences, sleep duration, physical exercise, high density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol levels were significantly lower in the occurrence group than in the control group (all P < .05). Multivariate logistic analysis showed that smoking history, duration of diabetes, Framingham score, SBP, TC, FBG, HDL-C, 2h postprandial plasma glucose, and Hcy levels were risk factors for cardio- and cerebrovascular disease in elderly patients with T2DM. The area under the curve for Hcy and Framingham scores was 0.741 (95% confidence interval [CI]: 0.635–1.871) and 0.717 (95% CI: 0.601–0.856), respectively. Hcy combined with the Framingham score demonstrated a significantly higher predictive value (0.852, 95% CI: 0.741–0.979). Long smoking history, long diabetes duration, high Framingham score, high SBP, high TC, high FBG, low HDL-C, and high Hcy levels are risk factors for cardio-cerebrovascular disease in elderly patients with T2DM. In addition, Hcy level combined with the Framingham score demonstrated superior predictive power for cardio- and cerebrovascular disease in elderly patients with T2DM. Lippincott Williams & Wilkins 2023-10-06 /pmc/articles/PMC10553110/ /pubmed/37800767 http://dx.doi.org/10.1097/MD.0000000000035401 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC) (https://creativecommons.org/licenses/by-nc/4.0/) , where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal.
spellingShingle Observational Study
Wang, Lei
Wang, Zhao Hui
Liu, Ling Peng
Value of Hcy combined with Framingham score for predicting macrovascular disease in elderly patients with type 2 diabetes
title Value of Hcy combined with Framingham score for predicting macrovascular disease in elderly patients with type 2 diabetes
title_full Value of Hcy combined with Framingham score for predicting macrovascular disease in elderly patients with type 2 diabetes
title_fullStr Value of Hcy combined with Framingham score for predicting macrovascular disease in elderly patients with type 2 diabetes
title_full_unstemmed Value of Hcy combined with Framingham score for predicting macrovascular disease in elderly patients with type 2 diabetes
title_short Value of Hcy combined with Framingham score for predicting macrovascular disease in elderly patients with type 2 diabetes
title_sort value of hcy combined with framingham score for predicting macrovascular disease in elderly patients with type 2 diabetes
topic Observational Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553110/
https://www.ncbi.nlm.nih.gov/pubmed/37800767
http://dx.doi.org/10.1097/MD.0000000000035401
work_keys_str_mv AT wanglei valueofhcycombinedwithframinghamscoreforpredictingmacrovasculardiseaseinelderlypatientswithtype2diabetes
AT wangzhaohui valueofhcycombinedwithframinghamscoreforpredictingmacrovasculardiseaseinelderlypatientswithtype2diabetes
AT liulingpeng valueofhcycombinedwithframinghamscoreforpredictingmacrovasculardiseaseinelderlypatientswithtype2diabetes